Showing results (1591-1600 of 2,100) with videos related to

Sort By:
Pageof 210
International Journal of Cancer|March 7, 2020
Phase 1 study of epacadostat in combination with atezolizumab for patients with previously treated advanced nonsmall cell lung cancerMatthew D Hellmann, Scott Gettinger, Laura Q M Chow, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 12, 2014
Phase 2 trial of paclitaxel, 13-cis retinoic acid, and interferon alfa-2b in the treatment of advanced stage or recurrent cervical cancerMihae Song, Robert S DiPaola, Bernadette M Cracchiolo, et al.
Diabetes, Obesity & Metabolism|July 1, 2022
The effect of curcumin on hepatic fat content in individuals with obesityPernille H Hellmann, Jonatan I Bagger, Katrine R Carlander, et al.
Molecular Ecology|March 20, 2017
Chironomus riparius (Diptera) genome sequencing reveals the impact of minisatellite transposable elements on population divergenceAnn-Marie Oppold, Hanno Schmidt, Marcel Rose, et al.
Ecology and Evolution|September 16, 2024
Range-wide population genomic structure of the Karner blue butterfly, Plebejus (Lycaeides) samuelisJing Zhang, Aaron W Aunins, Timothy L King, et al.
Arthritis and Rheumatism|April 16, 2002
Temporal arteritis and Chlamydia pneumoniae: failure to detect the organism by polymerase chain reaction in ninety cases and ninety controlsMichael J Regan, Billie Jo Wood, Yu-Hsiang Hsieh, et al.
The Journal of Infectious Diseases|January 3, 2001
Phenotypic drug susceptibility testing predicts long-term virologic suppression better than treatment history in patients with human immunodeficiency virus infectionS A Call, M S Saag, A O Westfall, et al.
Physical Review Letters|October 15, 2008
Field and temperature dependence of the superfluid density in LaFeAsO1-xFx superconductors: a muon spin relaxation studyH Luetkens, H-H Klauss, R Khasanov, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 13, 2010
Pharmacokinetics of Optivate(®), a high-purity concentrate of factor VIII with von Willebrand factor, in patients with severe haemophilia AA Dmoszynska, A Hellmann, T Baglin, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 5, 2011
Clinical assessment of Optivate®, a high-purity concentrate of factor VIII with von Willebrand factor, in the management of patients with haemophilia AA Dmoszynska, K Kuliczkowski, A Hellmann, et al.
Pageof 210